Electronic Data Capture

Electronic data capture (EDC) is a computerized system designed for the collection, management, and storage of clinical research data, replacing traditional paper based case report forms with electronic forms that participants, research staff, or clinicians complete on computers, tablets, or smartphones. EDC systems enforce data validation rules at the point of entry, generate automatic audit trails, and enable real time remote monitoring of data quality.^[1] Widely used EDC platforms include REDCap, Medidata Rave, Oracle InForm, and Castor EDC.

Data quality in clinical trials directly affects the reliability of study results and the success of regulatory submissions. Paper based data collection introduces transcription errors, illegible entries, missing data, and delays between data generation and availability for monitoring. EDC systems address these problems by standardizing the data entry process, preventing out of range values and logical inconsistencies at the point of entry, and making data available for review in real time. Regulatory agencies including the FDA and EMA accept and encourage the use of EDC systems, provided they meet requirements for data integrity, security, and auditability: in the US, 21 CFR Part 11 on electronic records and electronic signatures; in the EU, the EMA guideline on computerised systems and electronic data in clinical trials (in effect since September 2023); and internationally, the computerized systems provisions of the ICH E6(R3) Good Clinical Practice guideline.^[2][3][4] The COVID 19 pandemic accelerated the adoption of EDC and remote data capture, as on site monitoring visits were often restricted or suspended and decentralized trial designs required digital data collection.

An EDC system consists of a central database, a web based or application based user interface for data entry, an administrative layer for user management and role based access control, and a reporting module for data exports and monitoring dashboards. Before the study begins, the EDC system is programmed with the study's data collection forms (electronic case report forms or eCRFs), which define the fields, data types, validation rules, and skip logic for each data element.^[1]

Validation rules enforce data quality at the point of entry. Range checks prevent impossible values (such as a heart rate of 500). Logic checks flag inconsistencies (such as a pregnancy test result entered for a male participant). Required field enforcement prevents forms from being submitted with missing critical data. Edit checks generate queries when entered values are suspicious but not impossible, prompting the data entry person to verify or correct the entry.

The audit trail is a critical feature for regulatory compliance. It automatically records every data entry, modification, and deletion, including the identity of the person who made the change, the date and time, the original value, the new value, and the reason for the change. This creates a complete, tamper evident history of all data in the system. Regulators expect such audit trails: in the US, 21 CFR Part 11 requires secure, computer generated, time stamped audit trails in which record changes do not obscure previously recorded information, and ICH E6(R3) expects audit trails to show the initial entry and each change, by whom, when and, where applicable, why.^[2][3][4] An audit trail alone does not satisfy data integrity requirements: under ICH E6(R3), the system, including the study specific checks and calculations, should also be validated before use, with the extent of validation based on a risk assessment.^[2]

Real time monitoring allows the study sponsor or coordinating center to review data as they are entered, rather than waiting for periodic on site monitoring visits. This enables earlier detection of data quality problems, protocol deviations, and enrollment issues. Electronic signatures replace handwritten signatures for form completion and data verification, with authentication mechanisms that must meet regulatory standards for electronic signatures, such as 21 CFR Part 11 in the US.^[4]

EDC is appropriate for any clinical trial, clinical study, or research project where data quality, regulatory compliance, remote access, and efficient data management are priorities. It is the standard in industry sponsored clinical trials and is increasingly used in academic research; regulators accept data from EDC systems that meet their requirements, but they do not require EDC as such. REDCap is widely available at academic institutions at no cost and is suitable for investigator initiated studies of any size.^[1] EDC is less appropriate for very small studies where the setup cost can outweigh the benefits, or for studies in settings with unreliable internet access where offline capable systems or hybrid approaches may be needed.

A multicenter Phase III trial of a cardiovascular drug uses Medidata Rave EDC across 85 sites in 12 countries. The system contains 23 eCRFs with 340 data fields, including 178 validation rules and 46 edit checks. Real time monitoring dashboards allow the data management team to track enrollment rates, query resolution times, and missing data percentages by site. Over the course of the trial, the EDC system generates 12,400 queries, of which 94% are resolved within the target timeline of 14 days. The audit trail records 890,000 data modifications, all traceable to specific users with timestamps and reasons. At the end of the trial, the database is locked after a final data review confirming that all queries are closed and 99.7% of expected data fields are complete, with the remaining fields documented as missing.